| Drug Type Small molecule drug | 
| Synonyms Clorpres, Combipres | 
| Action agonists, inhibitors | 
| Mechanism ADRA2B agonists(Alpha-2b adrenergic receptor agonists), NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors), α2A-AR agonists(Alpha-2a adrenergic receptor agonists) | 
| Therapeutic Areas- | 
| Active Indication- | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhaseWithdrawn | 
| First Approval Date United States (03 Sep 1974) | 
| Regulation- | 
| Molecular FormulaC14H11ClN2O4S | 
| InChIKeyJIVPVXMEBJLZRO-UHFFFAOYSA-N | 
| CAS Registry77-36-1 | 
| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| - | - | - | 





